The use of electronic cigarettes (vapes), a relatively recent form of nicotine consumption, has been consolidated into a global epidemic, with rising prevalence particularly among young people—including adolescents aged 13 to 24 years.(1) Created by Chinese pharmacist Hon Lik in 2003,(2,3) the device initially failed to gain widespread acceptance. The patent was later transferred to the tobacco industry, which heavily invested in marketing strategies emphasizing aesthetic appeal, a variety of flavors, attractive colors, innovative design, and the misleading claim that the product contained only water vapor and was harmless to health.(4-6)
 
These claims were swiftly refuted by scientific evidence and clinical experience, as reports have accumulated significant respiratory, cardiovascular, and mental health damage.(7-11) In 2019, an outbreak of a previously undescribed pulmonary condition—E-cigarette or Vaping product use-Associated Lung Injury (EVALI)—was recorded, causing 68 deaths among young people in the United States, with cases and fatalities subsequently reported in other countries, including Brazil.(12)
 
In Brazil, the sales, transportation, and advertising of electronic cigarettes have been prohibited since 2009 by the Brazilian Health Regulatory Agency,(13) a policy mirrored in countries such as Mexico, India, and Argentina. Conversely, nations such as Canada, the United States, and the United Kingdom have implemented additional restrictive measures, including raising the minimum purchase age, banning certain flavors, and limiting nicotine content.(6,14,15)
 
The appeal of electronic cigarettes has been heightened by the constant technological evolution of their devices. in 2024, data from the Brazilian national Telephone-based System for the Surveillance of Risk and Protective Factors for Chronic Diseases indicated that the average age of experimentation was around 13 years; that consumption was higher among boys; and that overall smoking prevalence increased from 9% in 2023 to 11.6% in 2024, possibly driven by vape use among youth.(16,17) This scenario raises pressing questions: Has there been a relaxation in communication with the public and the medical community? Were there failures in enforcement and product seizures? Was there underestimation of the severity of the problem? Meanwhile, the tobacco industry’s lobbying power continues to influence the public and policymakers.
 
Structurally, e-cigarettes have four main components: a lithium battery, a tank, an atomizer, and a mouthpiece. Heating above 350°C produces an aerosol containing ultrafine particles and a complex mixture of chemicals—propylene glycol, glycerin, nitrites, heavy metals (such as lead and nickel),(8,10,18) diacetyl, benzoic acid, and flavorings. Additionally, synthetic nicotine, nicotine salts, cannabis derivatives (CBD, THC), and amphetamines have been identified—all of which capable of inducing strong dependence—as shown in recent studies, including research conducted in Brazil by two important Brazilian universities.(18,19)
 
These devices primarily attract individuals who had never smoked, along with a smaller proportion of combustible cigarette smokers seeking, often mistakenly, to reduce health risks. However, national and international data show that dual use (conventional + electronic cigarettes) remains frequent and is increasing.(20,21)
 
The narrative review published by Martins et al.(22) in this issue of the Jornal Brasileiro de Pneumologia provides health professionals with a broad approach to vape cessation, including behavioral support, nicotine replacement therapy (NRT), and non-nicotine pharmacological treatments. While this review is both relevant and timely, it is important to note that the scientific literature on vape cessation is still limited, frequently relying on studies with small sample sizes. Consequently, the review article featured in this issue makes a valuable contribution, highlighting the necessity for further research that specifies sample sizes and confidence intervals. On the other hand, it is important to stress that some studies referred in this review involve medications unavailable in Brazil, such as varenicline and cytisine, which could mislead clinical practice.
 
Another important aspect that warrants attention is that NRT has yet to be specifically validated for e-cigarette dependence. This is not unexpected, given the only recent rise in electronic cigarette use. However, caution is advised when applying the findings from NRT studies focused on traditional cigarette smokers to those who use electronic cigarettes.
 
Cognitive behavioral therapy, delivered individually or in groups, plays a central role in managing this population, composed mainly of young people undergoing physical and psychological maturation, with greater neuroplasticity and vulnerability to social influences.(14,23) Cognitive-behavioral strategies that encourage reflection on self-image (“How do I see myself? How do I see the world? How do I think the world sees me?”), world perception, and social integration can help develop coping strategies for chemical and behavioral dependence. Complementary resources include physical, cultural, artistic, and manual activities, support apps, peer networks, and vape-free environments.
 
Applying theoretical models such as the stages of change,(24,25) and validated instruments for dependence assessment (Penn State Nicotine Dependence Index, Modified Fagerström for e-cigs) can refine therapeutic planning. However, the high nicotine levels in vapes—often exceeding those in conventional cigarettes—pose challenges for simply adapting usual NRT regimens. Continuous NRT combined with rapid-release forms during peak cravings may be considered, always alongside intensive behavioral support.
 
It is important to note that the recommendations discussed here do not constitute formal guidelines, but rather provisional guidance. As with conventional smoking, pharmacological treatment in adolescents must be used with extreme caution and close follow-up, with behavioral therapy as the first-line approach.
 
To sum up, medical societies and health authorities must invest in continuing education, provide educational materials, and consolidate clinical protocols to ensure safe and effective professional practice in addressing e-cigarette dependence.
 
REFERENCES
 
1.           Hammond D, Reid JL, Rynard VL, Fong GT, Czoli CD. Trends in vaping and smoking among adolescents in Canada, England and the USA from 2017 to 2022: repeat national cross-sectional surveys. BMJ. 2023;381:e073946.
2.           REPod. História do vape: a invenção chinesa e a trajetória de Hon Lik [Internet]. São Paulo: REPod; 2023 [citado 2025 ago 11]. Available from: https://repod.com.br/historia-do-vape
3.           Hon L. The electronic cigarette: personal account of invention. China Tob Sci. 2020;1:1-5.
4.           Rede pela Política de Controle do Tabaco [homepage on the Internet]. São Paulo: Rede ACT; c2023 [cited 2025 Aug 11] Desafios e estratégias para conter o uso de cigarros eletrônicos no Brasil. Available from: https://actbr.org.br/post/desafios-e-estrategias-para-conter-o-uso-de-cigarros-eletronicos-no-brasil/18772
5.           Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Exposure to toxicants in electronic cigarette aerosols: recent findings and research needs. Tob Control. 2024;33(3):263-70.
6.           World Health Organization. Electronic nicotine delivery systems: report by the Director-General. Geneva: WHO; 2023.
7.           Instituto Nacional de Câncer José Alencar Gomes da Silva. Observatório Nacional de Saúde [homepage on the Internet]. Rio de Janeiro: INCA; c2023 [cited 2025 Aug 11]. Relatório sobre dispositivos eletrônicos para fumar. Available from: https://www.inca.gov.br/observatorio-da-politica-nacional-de-controle-do-tabaco
8.           Omaiye EE, McWhirter KJ, Luo W, Tierney PA, Pankow JF, Talbot P. Quantification of 16 metals in e-cigarette fluids and aerosols. Environ Health Perspect. 2025;133(4):047009. https://doi.org/10.1289/EHP15648
9.           Toledo EFV, Silva RN, Andrade JF, Oliveira L, Santos AG. Harmful compounds in e-cigarette aerosols: a comprehensive review. Toxics. 2025;13(4):268. https://doi.org/10.3390/toxics13040268
10.        Yang BR, Kim HJ, Lee SH, Park JH, Choi YH. Electronic cigarette use and heavy metal exposure: implications for human health. Sci Total Environ. 2025;931:173122.
11.        Zhao S, Zhang L, Yuan M, Li J, Wang X. Carcinogenic and non-carcinogenic health risk assessment of electronic cigarette aerosols. Sci Rep. 2023;13(1):17456. https://doi.org/10.1038/s41598-023-43112-y
12.        U.S. Department of Health and Human Services. Health consequences of electronic cigarette use: 2022 report of the Surgeon General. Washington, DC: USDHHS; 2022.
13.        Agência Nacional de Vigilância Sanitária [homepage on the Internet]. Brasília: ANVISA; c2024 [cited 2025 Aug 11]. Resolução RDC nº 46, de 28 de agosto de 2009: proibição da comercialização, importação e propaganda de cigarros eletrônicos [Internet]. Available from: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-atualiza-regulacao-de-cigarro-eletronico-e-mantem-proibicao/DPSEI_ANVISA2917085Voto.pdf
14.        Greenhalgh EM, Scollo MM, Winstanley MH. Tobacco in Australia: facts and issues, electronic cigarettes chapter update 2024. Melbourne: Cancer Council Victoria; 2024.
15.        U.S. Food and Drug Administration [homepage on the Internet]. Silver Spring: FDA; c2025 [cited 2025 Aug 11]. Results from the Annual National Youth Tobacco Survey. Available from: https://www.fda.gov/tobacco-products/youth-and-tobacco/results-annual-national-youth-tobacco-survey-nyts
16.        Ministério da Saúde (Brasil). Pesquisa Nacional de Saúde do Escolar 2019: relatório final. Brasília: MS; 2020.
17.        Revista Pesquisa FAPESP [homepage on the Internet]. São Paulo: FAPESP; c2024 [cited 2025 Aug 11]. Levantamento registra alta adesão de jovens aos vapes no Brasil Available from: https://revistapesquisa.fapesp.br/levantamento-registra-alta-adesao-de-jovens-aos-vapes/
18.        Polícia Científica de Santa Catarina; Universidade Federal de Santa Catarina [homepage on the Internet] Florianópolis: UFSC; c2024 [cited 2025 Aug 11].. Estudo toxicológico revela presença de octodrina (DMHA) em cigarros eletrônicos apreendidos. Available from: https://www.policiacientifica.sc.gov.br/2024/07/02/estudo-da-pcisc-e-ufsc-revela-perigos-ocultos-dos-cigarros-eletronicos-presenca-de-substancia-semelhante-a-anfetamina
19.        Faculdade de Medicina da Universidade de São Paulo [homepage on the Internet]. São Paulo: USP; c2025 [cited 2025 Aug 11]. Pesquisa inédita sobre perfil de usuários de cigarros eletrônicos no Brasil. Available from: https://www.incor.usp.br/sites/incor2024/imprensa/194/incor-divulga-pesquisa-inedita-sobre-cigarros-eletronicos
20.        Soneji S, Barrington-Trimis JL, Leventhal AM, Unger JB. E-cigarettes and the risk of cigarette smoking initiation: updated evidence from prospective studies (2019-2024). JAMA Pediatr. 2024;178(2):198-206.
21.        Barrington-Trimis JL, Leventhal AM. Adolescent vaping and nicotine addiction: new perspectives and challenges. Pediatrics. 2023;152(1):e2022060490.
22.        Martins SR, Correa PCRP, Costa C, Sousa MG, Tourinho CAP, Borges VLG. Vaping cessation: how to treat nicotine dependence and tailor the nicotine replacement dose. A narrative review. J Bras Pneumol. 2025;51(4):e20250061.
23.        Primack BA, Soneji S, Villanti A, Stanton CA, McConnell RS. Nicotine and the adolescent brain revisited: insights from 2020-2023 research. iScience. 2023;25(6):104294.
24.        DiClemente CC, Prochaska JO. Self-change and therapy-change of smoking behavior: a comparison of processes of change of cessation and maintenance. Addict Behav. 1982;7:133-42. https://doi.org/10.1016/0306-4603(82)90038-7
25.        Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390-5. https://doi.org/10.1037/0022-006X.51.3.390
26.        Sociedade Brasileira de Cardiologia. Posicionamento oficial sobre dispositivos eletrônicos para fumar. Arq Bras Cardiol. 2024;122(6):1-12.
27.        Kreslake JM, Wayne GF, Allem JP, Noar SM, Wills TA. E-cigarette use among youths and young adults during and after the COVID-19 pandemic. Am J Public Health. 2021;111(6):1123-30. https://doi.org/10.2105/AJPH.2021.306210
28.        Freeman M, Hsu CC, Villajuana C, Shearer L, Hatsukami D, Leyro T, et al. Development and validation of the Penn State Electronic Cigarette Dependence Index. Nicotine Tob Res. 2019;21(10):1556-64.